These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19125944)

  • 1. Treatment of minimal hepatic encephalopathy.
    Kumashiro R
    Hepatol Res; 2008 Nov; 38 Suppl 1():S128-31. PubMed ID: 19125944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
    Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
    Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis.
    Wibawa IDN; Mariadi IK; Shalim CP; Sindhughosa DA
    Clin Exp Hepatol; 2023 Jun; 9(2):146-153. PubMed ID: 37502435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
    Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
    J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial.
    Pratap Mouli V; Benjamin J; Bhushan Singh M; Mani K; Garg SK; Saraya A; Joshi YK
    Hepatol Res; 2015 Aug; 45(8):880-9. PubMed ID: 25266207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
    Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
    J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of overt hepatic encephalopathy.
    Sharma P; Sharma BC
    J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S82-7. PubMed ID: 26041964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial.
    Mousa N; Abdel-Razik A; Zaher A; Hamed M; Shiha G; Effat N; Elbaz S; Elhelaly R; Hafez M; El-Wakeel N; Eldars W
    Therap Adv Gastroenterol; 2016 Sep; 9(5):684-91. PubMed ID: 27582881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
    Cai XJ; Wang L; Hu CM
    J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal.
    Pawar VB; Surude RG; Sonthalia N; Zanwar V; Jain S; Contractor Q; Rathi PM
    J Clin Transl Hepatol; 2019 Dec; 7(4):304-312. PubMed ID: 31915599
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral l-ornithine-l-aspartate in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled trial.
    Alvares-da-Silva MR; de Araujo A; Vicenzi JR; da Silva GV; Oliveira FB; Schacher F; Oliboni L; Magnus A; Kruel LP; Prieb R; Fernandes LN
    Hepatol Res; 2014 Sep; 44(9):956-63. PubMed ID: 24033861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.